For Immediate Release
Chicago, IL – August 2, 2012 – Zacks Equity Research highlights Biogen Idec (BIIB) as the Bull of the Day and McDonald's Corp. (MCD) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Sunoco (SUN), PHH Corp (PHH) and FreightCarAmerica (RAIL).
Full analysis of all these stocks is available at http://at.zacks.com/?id=2678.
Here is a synopsis of all five stocks:
Biogen Idec's (BIIB) second quarter EPS of $1.82 was well above the Zacks Consensus Estimate of $1.56 and the year-ago EPS of $1.35. Higher revenues and a lower share count boosted earnings. Second quarter 2012 revenues increased 17.6% to $1.4 billion, well above the Zacks Consensus Estimate of $1.3 billion.
Biogen increased its earnings outlook for 2012 and now expects EPS to exceed $6.20. Estimates have been on the rise following the release of strong second quarter results. The Zacks Consensus Estimate for 2012 has gone up by 19 cents to $6.33 per share. We are upgrading the stock to Outperform.
Key products Avonex and Tysabri should continue contributing significantly to sales. BG-12 should help drive long-term growth. Meanwhile, Biogen's restructuring initiative should help drive the bottom line. We are also pleased with Biogen's efforts to streamline its pipeline.
McDonald's Corp. (MCD) enjoyed increased global same-store sales and moderate growth prospects with its exposure to faster-growing international markets, a strong balance sheet and consistent earnings. However, its lower-than-expected earnings and revenue in the second quarter came as a shock.
The macroeconomic headwinds, especially in Europe, decelerating growth in Asia and higher commodity and labor costs globally will likely impede sales and margin expansion of McDonald's going forward. Moreover, intense competition and increased selling, general and administrative expenses, rising tax rates as well as the expected currency headwinds for 2012 add woe to the worry.
Hence, in the face of underwhelming earnings report and decelerating same-store sales momentum, we downgrade the stock from Neutral to Underperform recommendation. Our six-month target price of $81.00 equates to 14.9x our earnings estimate for fiscal 2012.
Latest Posts on the Zacks Analyst Blog:
Earnings ESP: A Leading Indicator
As my good friend and Zacks Research Director Sheraz Mian noted in his comments earlier this week, we have entered into the last “major” week of earnings of the S&P 500.
So far, total earnings growth for the roughly 320 companies that have already reported are up 5.3% year over year, about 2/3rds of them beating expectations with a median surprise of 2.7%. While that seems like a positive, there are some “details” that we need to be aware of.
If you look back just one quarter (Q1) before the most recent downward analyst revisions, this quarter’s earnings results would have actually been about 4% lower than expectations.
Top line revenue is also lower on average than it was in the year ago period which is an indication that overall sales of goods and services are down. That said, there are some companies that are truly surprising the markets to the upside and offering bullish outlooks for the coming year; those companies are being rewarded with huge gains.
We saw this type of action in Netquite last week, which was one of my selections for my Whisper Trading Service.
It’s fair to say that the most recent earnings season is mediocre at best, but being that expectations were ridiculously low, the markets are at least remaining stable. It’s also safe to assume that the past week’s bullish action can be partially attributed to strong, supportive words from the likes of Mario Dragi and Mr Juncker on the stability of the Euro Zone by any means necessary.
The US markets are also looking to the Fed for additional QE here, but I think that our European friends may have bought the Fed another month or two until they enact any further stimulus. We will see later today if that thesis holds true.
About Zacks Earnings ESP
Earnings ESP is Zacks’ proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Zacks Consensus.
The Zacks ESP helps predict earnings surprises to the upside and downside; the greater the ESP (positive or negative) the greater the likelihood for a surprise.
I use ESP to help quantify the conviction of the analysts for a surprise and stack the odds in my favor when I combine it with other measurements and statistics.
This can work for bullish potential surprises (positive ESP) as well as bearish surprises (negative ESP).
Let’s check out a few bullish ESP candidates that report over the next week or so:
Bullish ESP Stocks
Sunoco (SUN) - is a Zacks Rank 3 stock with an earnings ESP of 25% for Q2. Their FY2013 ESP is 7%. Sunoco does have some weakness in their Q3 and FY2012 ESPs, but hopefully a beat in this quarter and longer term strength will support the shares.
The Zacks consensus estimate is for 47 cents of income this quarter, with the most accurate estimate at 58 cents. Expectations may be lower because they have missed analysts expectations for 3 of the last 4 quarters.
Sunoco, Inc. is principally a petroleum refiner and marketer with interests in cokemaking. Sunoco's petroleum refining and marketing operations include the manufacturing and marketing of a full range of petroleum products, including fuels, lubricants and petrochemicals, and the transportation of crude oil and refined products. These operations are conducted principally in the eastern half of the United States
– Sunoco reports earnings on August 2nd AMC (after market close).
PHH Corp (PHH) - is a Zacks Rank 2 stock with a Q2 earnings ESP of 22%. The Zacks consensus estimate is for Q2 earnings of $0.82, with the most accurate estimate at $1.00. PHH Corp has exceeded analysts’ expectations by an average of 24% over the past four quarters.
Analyst momentum also looks bullish for the current and next quarters as well as FY2012 and FY2013
PHH Corp is a leading outsource provider of mortgage and vehicle fleet management services. It is the sixth largest retail originator of residential mortgages in the United States and the second largest fleet management services provider in the United States and Canada. – PHH reports earnings on August 7th AMC
FreightCar America (RAIL) - is a Zacks Rank 2 stock with a Q2 earnings ESP of 23%. The Zacks consensus estimate is for Q2 EPS of $0.57, with the most accurate estimate at $0.70. FreightCar has reported two strong earnings reports back to back, more than doubling estimates both times. In Q32011, they did experience a major miss and reported a 20 cent loss versus Zacks estimates for a 3 cent profit.
Analyst momentum is mixed in FreightCar and Avondale partners recently reduced their estimates for the stock in Q2 to 57 cents. In Q3 as well FY2012 and 2013, Avondale dropped their estimates below the Zacks consensus. I think it’s safe to say that expectations are low. RAIL shares has responded positively to the last 3 earnings reports.
FreightCar America, Inc. manufactures railroad freight cars, with particular expertise in coal-carrying railcars. In addition to coal cars, FreightCar America designs and builds flat cars, mill gondola cars, intermodal cars, coil steel cars and motor vehicle carriers. It is headquartered in Chicago, Illinois and has manufacturing facilities in Danville, Illinois, Roanoke, Virginia and Johnstown, Pennsylvania.
– FreightCar America reports earnings on August 6th BMO (before market open).
Get the full analysis of all these stocks by going to http://at.zacks.com/?id=2649.
About the Bull and Bear of the Day
Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.
About the Analyst Blog
Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment
Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4582.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Zacks Investment Research
800-767-3771 ext. 9339
More From Zacks.com
- Investment & Company Information
- Biogen Idec
- Biogen Idec